Companies: 10,795·Total market cap: $144.5T
Curaleaf Holdings, Inc.

Curaleaf Holdings, Inc.

CURLFOTCHealthcare● Active
$11.51
+$0.59(+5.40%)
Market Cap$3.0B
P/E Ratio
52W High$11.51
52W Low$0.72

Curaleaf Holdings, Inc. (CURLF) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

curlf · pe ratio · data through Dec 31, 2025

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for Curaleaf Holdings, Inc. (CURLF) measures how much investors pay for each dollar of the company's trailing earnings. CURLF's current PE ratio of N/A is calculated by dividing its stock price of $11.51 by its TTM earnings per share of -$0.40.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31

Forward P/E
N/A
FY2027 est. EPS $-0.17
Based on 3 analysts
EPS (TTM)
-$0.40
TTM · diluted EPS
PEG Ratio
-0.54
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Curaleaf Holdings, Inc. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-08

PE Ratio History

2014 – 2025 · Annual
PE Ratio (TTM)
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Drug Manufacturers - Specialty & Generic · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
Curaleaf Holdings, Inc.
Curaleaf Holdings, Inc.You
CURLF
$3.0BN/A-$0.40
Fagron N.V.
Fagron N.V.
ARSUF
$2.0B16.06x-74.5%$1.25
CanSino Biologics Inc.
CanSino Biologics Inc.
CASBF
$1.4B309.29x+390.3%$0.11
China Medical System Holdings Limited
China Medical System Holdings Limited
CHSYF
$2.3B15.75x-75.0%$0.60
Dermapharm Holding SE
Dermapharm Holding SE
DMPHF
$2.9B13.70x-78.3%$2.46
HUTCHMED (China) Limited
HUTCHMED (China) Limited
HMDCF
$2.5B6.86x-89.1%$0.53
Hisamitsu Pharmaceutical Co., Inc.
Hisamitsu Pharmaceutical Co., Inc.
HTSUF
$2.0B16.80x-73.4%$269.34
Industry Average
6 peers with valid PE
63.08xbaseline

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 10 of 12 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2025-12-31Latest
FY2025
$-0.93
2024-12-31
FY2024
$-0.92
2023-12-31
FY2023
$-1.19
2022-12-31
FY2022
$-1.50
2021-12-31
FY2021
$-0.88
2020-12-31
FY2020
$-0.32
2019-12-31
FY2019
$-0.45
2018-12-31
FY2018
$-0.41
2017-12-31
FY2017
$-0.03
2016-12-31
FY2016
$-0.31

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for Curaleaf Holdings, Inc. (CURLF) measures how much investors pay for each dollar of the company's trailing earnings. CURLF's current PE ratio of N/A is calculated by dividing its stock price of $11.51 by its TTM earnings per share of -$0.40.

PE Ratio = Stock Price ÷ EPS (TTM)
= $11.51 ÷ -$0.40 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

CURLF pe ratio · 6 questions

CURLF's current PE ratio is N/A as of 2026-06-08, based on a stock price of $11.51 and TTM EPS of -$0.40. Data sourced from Financial Modeling Prep via CURLF's SEC 10-K and 10-Q filings.

CURLF PE ratioWhat is CURLF PE ratioCurrent PE ratio of CURLFCURLF PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Curaleaf Holdings, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08